-
Product Insights
Female Sexual Dysfunction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Female Sexual Dysfunction Pipeline Drugs Market Overview Female sexual dysfunction occurs when a woman is not able to fully, healthily, and pleasurably experience some or all of the various physical stages the body normally experiences during sexual activity. The predisposing factors include depression or anxiety, heart and blood vessel disease, liver or kidney failure, and certain medications, such as antidepressants or high blood pressure medications. Treatment includes estrogen therapy. The female sexual dysfunction pipeline market research report provides comprehensive information...
-
Sector Analysis
Endometriosis Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2020-2030
Endometriosis Market Report Overview The endometriosis market size across the 7MM was $1.05 billion in 2020 and is expected to achieve a CAGR of more than 9% during 2020-2030. The greater diagnosed prevalence of endometriosis in the US compared to the 5EU and Japan and the higher price of drugs compared to the other global markets are key factors responsible for the high endometriosis market sales. Endometriosis is a common gynecological condition affecting women of reproductive ages. Women with endometriosis...
-
Sector Analysis
EpiCast Report: Endometriosis – Epidemiology Forecast to 2025
Endometriosis is an estrogen-dependent disorder characterized by growth and appearance of endometrial cells or tissues in locations outside the uterus, which results in a series of chronic inflammatory reactions leading to scarring of tissues and adhesions of fibrous tissues in the pelvic region. The condition is often associated with severe dysmenorrhea, chronic pelvic pain, chronic fatigue, deep dyspareunia, ovulation pain, abnormal bleeding, and infertility. Endometriosis has the potential to disrupt the quality of life of women, leading to emotional distress,...
-
Product Insights
Male Hypogonadism Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Male Hypogonadism Global Clinical Trials Review, H2, 2016" provides an overview of Male Hypogonadism clinical trials scenario. This report provides top line data relating to the clinical trials on Male Hypogonadism. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Vulval Atrophy Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Vulval Atrophy Global Clinical Trials Review, H1, 2016" provides an overview of Vulval Atrophy clinical trials scenario. This report provides top line data relating to the clinical trials on Vulval Atrophy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Dysmenorrhea Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Dysmenorrhea Global Clinical Trials Review, H2, 2017" provides an overview of Dysmenorrhea clinical trials scenario. This report provides top line data relating to the clinical trials on Dysmenorrhea. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Dyspareunia Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Dyspareunia Global Clinical Trials Review, H2, 2017" provides an overview of Dyspareunia clinical trials scenario. This report provides top line data relating to the clinical trials on Dyspareunia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Ectopic Pregnancy (Tubal Pregnancy) Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Ectopic Pregnancy (Tubal Pregnancy) Global Clinical Trials Review, H2, 2017" provides an overview of Ectopic Pregnancy (Tubal Pregnancy) clinical trials scenario. This report provides top line data relating to the clinical trials on Ectopic Pregnancy (Tubal Pregnancy). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Endometrial Hyperplasia Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Endometrial Hyperplasia Global Clinical Trials Review, H2, 2017" provides an overview of Endometrial Hyperplasia clinical trials scenario. This report provides top line data relating to the clinical trials on Endometrial Hyperplasia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Female Hypoactive Sexual Desire Disorder Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Female Hypoactive Sexual Desire Disorder Global Clinical Trials Review, H2, 2017" provides an overview of Female Hypoactive Sexual Desire Disorder clinical trials scenario. This report provides top line data relating to the clinical trials on Female Hypoactive Sexual Desire Disorder. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.